thyroid Hurthle cell carcinoma | ClinicalTrials HQ

View definition

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Studies on Tumors of the Thyroid	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thyroid Cancer, Papillary, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, papillary adenocarcinoma, thyroid Hurthle cell carcinoma, thyroid gland disorder, thyroid gland follicular carcinoma, thyroid tumor	Recruiting	Not stated	2026-10-08		NCT00001160
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer	Adenoma, Oxyphilic, Head and Neck Neoplasms, Hurthle Cell Tumor, Neoplasms by Histologic Type, Neoplasms by Site, Thyroid Cancer, Papillary, adenocarcinoma, adenoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, papillary adenocarcinoma, poorly differentiated thyroid gland carcinoma, thyroid Hurthle cell carcinoma, thyroid cancer, nonmedullary, 2, thyroid gland disorder, thyroid gland follicular carcinoma, thyroid tumor	Active, not recruiting	Phase 2	2026-09-17		NCT04544111
IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thyroid Cancer, Papillary, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, papillary adenocarcinoma, thyroid Hurthle cell carcinoma, thyroid gland disorder, thyroid gland follicular carcinoma, thyroid tumor	Active, not recruiting	Phase 2 / Phase 3	2026-05-07		NCT01398085
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer	thyroid Hurthle cell carcinoma	Active, not recruiting	Phase 2	2026-02-11		NCT02143726